<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the pivotal clinical trials of intravenous tissue plasminogen activator (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) therapy for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, a low rate of early arterial recanalization was suspected due to the small numbers of patients who had early dramatic clinical improvement </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="6" ids="15702,53394">TPA</z:chebi> activity can be enhanced with ultrasound including 2 MHz transcranial Doppler (TCD) </plain></SENT>
<SENT sid="2" pm="."><plain>TCD can identify residual signals around the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> with the thrombolysis in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> (TIBI) flow grading system and therefore expose more <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> surface to circulating <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>A phase I clinical study, monitoring <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> infusion with diagnostic ultrasound resulted in an unexpectedly high rate of complete recanalization (36% of proximal middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusions) and associated early dramatic clinical recovery (24%) among treated patients </plain></SENT>
<SENT sid="4" pm="."><plain>The external application of diagnostic ultrasound in our studies raised the possibility that a synergistic <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> and ultrasound action accelerated flow improvement and achieved faster and more complete <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> dissolution as predicted from experimental models </plain></SENT>
<SENT sid="5" pm="."><plain>The CLOTBUST (combined lysis of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> using transcranial ultrasound and systemic <z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) trial is testing this hypothesis in a phase II clinical randomized multi-center setting </plain></SENT>
<SENT sid="6" pm="."><plain>Dramatic clinical recovery from <z:hpo ids='HP_0001297'>stroke</z:hpo> and complete recanalization shortly after <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> bolus are feasible goals for thrombolysis assisted with TCD monitoring </plain></SENT>
</text></document>